Search

Displaying results 7421 - 7430 of 10000 in total
  1. Drug

    Tuvatidine

    go.drugbank.com/drugs/DB21229
    Experimental

    Tuvatidine is a small molecule drug. The usage of the INN stem '-tidine' in the name indicates that Tuvatidine is a histamine- H2​-receptor antagonist, cimetidine derivative. … Tuvatidine has a monoisotopic molecular weight of 391.07 Da.

  2. Drug

    Octaverine

    go.drugbank.com/drugs/DB21449
    Experimental

    Octaverine is a small molecule drug. The usage of the INN stem '-verine' in the name indicates that Octaverine is a spasmolytic with a papaverine-like action. … Octaverine has a monoisotopic molecular weight of 397.19 Da.

  3. Drug

    Icanbelimod

    go.drugbank.com/drugs/DB21572
    Experimental

    Icanbelimod is a small molecule drug. The usage of the INN stem '-imod' in the name indicates that Icanbelimod is a immunomodulator, both stimulant/suppressive and stimulant. … Icanbelimod has a monoisotopic molecular weight of 409.18 Da.

  4. Drug

    Uplarafenib

    go.drugbank.com/drugs/DB21661
    Experimental

    Uplarafenib is a small molecule drug. The usage of the INN stem '-rafenib' in the name indicates that Uplarafenib is a Raf (rapidly accelerated fibrosarcoma) kinase inhibitor. … Uplarafenib has a monoisotopic molecular weight of 494.12 Da.

  5. Drug

    Fosrolapitant

    go.drugbank.com/drugs/DB21723
    Investigational

    Fosrolapitant is a small molecule drug. The usage of the INN stem '-pitant' in the name indicates that Fosrolapitant is a neurokinin NK1​ (substance P) receptor antagonist. … Fosrolapitant has a monoisotopic molecular weight of 654.16 Da.

  6. Drug

    Flezurafenib

    go.drugbank.com/drugs/DB21725
    Experimental

    Flezurafenib is a small molecule drug. The usage of the INN stem '-rafenib' in the name indicates that Flezurafenib is a Raf (rapidly accelerated fibrosarcoma) kinase inhibitor. … Flezurafenib has a monoisotopic molecular weight of 456.16 Da.

  7. Drug

    Aspartyl-alanyl-diketopiperazine

    go.drugbank.com/drugs/DB14940
    Investigational

    Aspartyl-alanyl-diketopiperazine is under investigation in clinical trial NCT03349645 (An Open Label Extension Study to Assess the Safety of Long-Term Treatment With Ampion for Severe OA of the Knee).

  8. Drug

    EU204

    go.drugbank.com/drugs/DB17438
    Investigational

    EU204 (EBViNT) is an Epstein-Barr virus (EBV)-positive T-cell therapy currently undergoing phase 1 and 2a clinical trials in Korea for patients with EBV-positive lymphoma and solid cancer.

  9. Drug

    NOP-1A

    go.drugbank.com/drugs/DB15208
    Investigational

    NOP-1A is under investigation in clinical trial NCT01198197 (PET Brain and Whole Body Distribution Studies for Nociceptin/Orphanin FQ Peptide (NOP) Receptor Using [11C]NOP-1A).

    Synonyms: NOP-1A
  10. Drug

    TG4023

    go.drugbank.com/drugs/DB06108
    Investigational